Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.17 - $3.42 $48,285 - $971,382
-284,030 Closed
0 $0
Q3 2022

Nov 15, 2022

SELL
$0.24 - $1.11 $703 - $3,254
-2,932 Reduced 1.02%
284,030 $77,000
Q2 2022

Aug 15, 2022

SELL
$0.41 - $0.91 $545,227 - $1.21 Million
-1,329,823 Reduced 82.25%
286,962 $117,000
Q1 2022

May 16, 2022

SELL
$0.79 - $1.59 $16,014 - $32,232
-20,272 Reduced 1.24%
1,616,785 $1.34 Million
Q4 2021

Feb 14, 2022

SELL
$1.36 - $2.94 $129,648 - $280,270
-95,330 Reduced 5.5%
1,637,057 $2.23 Million
Q3 2021

Nov 15, 2021

SELL
$2.97 - $4.84 $20.3 Million - $33.1 Million
-6,846,384 Reduced 79.81%
1,732,387 $5.21 Million
Q2 2021

Aug 16, 2021

SELL
$3.71 - $5.13 $5.72 Million - $7.9 Million
-1,540,561 Reduced 15.22%
8,578,771 $39.6 Million
Q1 2021

May 17, 2021

BUY
$4.08 - $14.75 $27.8 Million - $100 Million
6,801,496 Added 205.0%
10,119,332 $43.5 Million
Q4 2020

Feb 16, 2021

BUY
$11.06 - $14.01 $9.66 Million - $12.2 Million
873,588 Added 35.74%
3,317,836 $36.7 Million
Q3 2020

Nov 10, 2020

SELL
$10.26 - $14.55 $781,093 - $1.11 Million
-76,130 Reduced 3.02%
2,444,248 $29.6 Million
Q2 2020

Aug 14, 2020

BUY
$7.11 - $13.76 $366,577 - $709,438
51,558 Added 2.09%
2,520,378 $34.7 Million
Q1 2020

May 11, 2020

BUY
$5.71 - $15.85 $14.1 Million - $39.1 Million
2,468,820 New
2,468,820 $19.1 Million

Others Institutions Holding ATNX

About Athenex, Inc.


  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.